Bianca Dumontel
Overview
Explore the profile of Bianca Dumontel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dumontel B, Rosso G, Cauda V
Nanomedicine (Lond)
. 2024 Feb;
19(8):653-655.
PMID: 38406890
No abstract available.
2.
Dumontel B, Jimenez-Jimenez C, Vallet-Regi M, Manzano M
Mater Today Bio
. 2023 Nov;
23:100850.
PMID: 38024844
In recent years, there has been a breakthrough in the integration of artificial nanoplatforms with natural biomaterials for the development of more efficient drug delivery systems. The formulation of bioinspired...
3.
Dumontel B, Conejo-Rodriguez V, Vallet-Regi M, Manzano M
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839771
In recent years, the functionalization of mesoporous silica nanoparticles (MSNs) with different types of responsive pore gatekeepers have shown great potential for the formulation of drug delivery systems (DDS) with...
4.
Jimenez-Jimenez C, Moreno-Borrallo A, Dumontel B, Manzano M, Vallet-Regi M
Acta Biomater
. 2022 Dec;
157:395-407.
PMID: 36476646
In the last few years, nanotechnology has revolutionized the potential treatment of different diseases. However, the use of nanoparticles for drug delivery might be limited by their immune clearance, poor...
5.
Dumontel B, Susa F, Limongi T, Vighetto V, Debellis D, Canta M, et al.
Cell Biosci
. 2022 May;
12(1):61.
PMID: 35568919
Background: We propose an efficient method to modify B-cell derived EVs by loading them with a nanotherapeutic stimuli-responsive cargo and equipping them with antibodies for efficient targeting of lymphoma cells....
6.
Limongi T, Susa F, Dumontel B, Racca L, Perrone Donnorso M, Debellis D, et al.
Membranes (Basel)
. 2021 Nov;
11(11).
PMID: 34832115
Cellular communications take place thanks to a well-connected network of chemical-physical signals, biomolecules, growth factors, and vesicular messengers that travel inside or between cells. A deep knowledge of the extracellular...
7.
Vighetto V, Racca L, Canta M, Matos J, Dumontel B, Goncalves M, et al.
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575499
Nanomedicine is an emerging treatment approach for many cancers, characterized by having high sensitivity and selectivity for tumor cells and minimal toxic effects induced by the conventional chemotherapeutics. In these...
8.
Zinc Oxide Nanocrystals and High-Energy Shock Waves: A New Synergy for the Treatment of Cancer Cells
Racca L, Limongi T, Vighetto V, Dumontel B, Ancona A, Canta M, et al.
Front Bioeng Biotechnol
. 2020 Jun;
8:577.
PMID: 32582682
In the last years, different nanotools have been developed to fight cancer cells. They could be administered alone, exploiting their intrinsic toxicity, or remotely activated to achieve cell death. In...
9.
Ancona A, Troia A, Garino N, Dumontel B, Cauda V, Canavese G
Ultrason Sonochem
. 2020 Apr;
67:105132.
PMID: 32339870
Nanoparticles able to promote inertial cavitation when exposed to focused ultrasound have recently gained much attention due to their vast range of possible applications in the biomedical field, such as...
10.
Susa F, Limongi T, Dumontel B, Vighetto V, Cauda V
Cancers (Basel)
. 2019 Dec;
11(12).
PMID: 31835327
Fast diagnosis and more efficient therapies for cancer surely represent one of the huge tasks for the worldwide researchers' and clinicians' community. In the last two decades, our understanding of...